Gelonghui November 23 | Unknown Pharmaceutical Notice. The company received the “Notice of Case Filing” issued by the China Securities Regulatory Commission on November 21. The China Securities Regulatory Commission decided to file a case against the company because the disclosure of the company's information was suspected of being illegal and illegal. Currently, the company's business conditions are normal.
未名医药：因涉嫌信披违法违规 遭证监会立案
Unknown drug: A case was filed by the Securities Regulatory Commission on suspicion of illegal disclosure
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.